Quick Summary:
Within the rapidly evolving biosciences field, the global transgenic animal market is proving to be of particular significance due to an escalating demand for animal-derived protein and dairy products, and increasingly advanced R&D activities. Transgenic animals, with their genetically modified genes, not only offer improvements in the quality and quantity of food production but also provide crucial insights into gene diseases.
The robust consumption patterns of animal-derived protein and dairy products have surged in recent years, highlighting the rising need for transgenic animals in global marketplaces, urban spaces, and increasingly populous regions. Genetically modified poultry, for instance, offers higher counts of easily digestible proteins. On a wider scale, the use of transgenic animals, especially in creating superior livestock strains, holds potential for addressing the challenges of a booming global population and shifting climate conditions. The medical and industrial applications of transgenic animals, with their capacity to unlock cures for conditions such as Alzheimer’s and cancer, reinforces their value in today's market.
To add, the national initiatives to promote awareness and fund R&D activities for transgenic animals have multiplied in recent times, bolstering the overall growth trajectory of the transgenic market. Collectively, these factors present an insightful and compelling case for investing in the transgenic animal market, which promises to continuously evolve and provide newer opportunities in the years ahead.
The Global Transgenic Animal Market is Anticipated to Observe an Impressive Growth due to Increasing Consumption of Animal-Derived Protein and Dairy Products and Rise in R&D Activities.
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Increasing Consumption of Animal-Derived Protein and Dairy Products
As protein and calcium plays a vital role in nutrition, the consumption of meat and meat products such as dairy products, eggs, beef, and chicken are increasing, which surge the market growth in foreseen years. For instance, genetically modified poultry, such as broilers, have high number of proteins which are easily digestible. Additionally, rapid urbanization and increase in population across the globe are bolstering the market growth. Owing to the increase in animal derived protein supplements and food products, the need for transgenic animals is also rising. Therefore, all these factors are propelling the growth of the transgenic animal market, globally. In 2015, a study by Meat and Livestock in Australia revealed that genetically modified cows can produce more milk and are less susceptible to cattle diseases.Wide Applications of Transgenic Animals
Transgenic animals have numerous applications in various fields such as agriculture, medical and industrial sectors. They are used to develop new and improved strains of livestock and as model organisms. Development of transgenic farm animals are allowing more flexibility in direct genetic manipulation of livestock. With ever-growing world population and changing climate conditions, such efficient means of increasing food production are needed. In addition, transgenic animals are specifically designed to study the genes in order to develop a cure for the diseases such as Alzheimer’s and cancer. For instance, in 2020, Merck Animal Health along with Automazioni VX, Inc. (US) signed an agreement aiming to Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be utilized by coupling with Merck Animal Health’s Innovax range of vaccines, which aids for protection against infectious diseases.Increasing awareness and R&D Initiatives
Various R&D initiatives and awareness programs are initiated by the governments of the respective countries, which is bolstering the growth of the transgenic market. As per a publication by the British Nutrition Foundation 2018, genetically modified cows were anticipated to produce milk without allergy-producing protein, which will make the product apt for lactose-intolerant people. As per the National Institute of Health, in 2017, approximately 8% of the population in the U.K. was suffering from lactose intolerance. Thus, the modifications are likely to provide newer prospects for animal genetics in the upcoming years. Furthermore, the rising initiative to educate on transgenic animal is further anticipated to drive the growth of this market.Market Segmentation
The global transgenic animal market is segmented into product, PCR, technique, application, model organism, end user and company. Based on product, the market is divided into gene gun, PCR, microinjections, and others. Based on PCR, the market is divided into real-time PCR, digital PCR System, and others. Based on technique, the market is segmented into DNA microinjection, embryonic stem cell-mediated gene transfer, retrovirus-mediated gene transfer, and others. Based on application, the market is segmented into recombinant human proteins, monoclonal antibodies, xenotransplantation, and others. Based on model organisms, the market is segmented into mice, rabbit, cow, and others. Based on end user, the market is segmented into biotechnology & pharmaceutical companies, academic & research organizations, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising animal-based protein food and growing occurrence of diseases in the country.Market Players Merck & Co., Inc., C.H. Boehringer Sohn Ko. KG, Randox Laboratories Limited, Zoetis, Inc., Virbac SA, Elanco Animal Health Inc., Biogénesis Bagó SA, Santa Cruz Biotechnology, Inc, Idexx Laboratories, Inc., and Innovative Diagnostics (IDVet) are some of the leading companies operating in the market.
Report Scope:
In this report, global transgenic animal market has been segmented into following categories, in addition to the industry trends which have also been detailed below:Transgenic Animal Market, By Product:
- Gene Gun
- PCR
- Real-Time PCR
- Digital PCR Systems
- Others
- Microinjections
- Others
Transgenic Animal Market, By Technique:
- DNA Microinjection
- Embryonic Stem Cell-Mediated Gene Transfer
- Retrovirus-Mediated Gene Transfer
- Others
Transgenic Animal Market, By Application:
- Recombinant Human Proteins
- Monoclonal Antibodies
- Xenotransplantation
- Others
Transgenic Animal Market, By Model Organisms:
- Mice
- Rabbit
- Cow
- Others
Transgenic Animal Market, By End User:
- Biotechnology & Pharmaceutical Companies
- Academic & Research Organizations
- Others
Transgenic Animal Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Transgenic Animal Market
Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Merck & Co., Inc.
- C.H. Boehringer Sohn Ko. KG
- Randox Laboratories Limited
- Zoetis, Inc.
- Virbac SA
- Elanco Animal Health Inc.
- Biogénesis Bagó SA
- Santa Cruz Biotechnology, Inc
- Idexx Laboratories, Inc.
- Innovative Diagnostics (IDVet)
